BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31162869)

  • 1. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
    Shi JY; Chen C; Xu X; Lu Q
    Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Xu X; Su YL; Shi JY; Lu Q; Chen C
    Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR.
    Zeng J; Wang L; Zhao J; Zheng Z; Peng J; Zhang W; Wen T; Nie J; Ding L; Yi D
    Hum Cell; 2021 Sep; 34(5):1388-1397. PubMed ID: 34138410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-19b-3p accelerates bone loss after spinal cord injury by suppressing osteogenesis via regulating PTEN/Akt/mTOR signalling.
    Liu D; Wang B; Qiu M; Huang Y
    J Cell Mol Med; 2021 Jan; 25(2):990-1000. PubMed ID: 33332749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-29-3p targets PTEN to regulate follicular development through the PI3K/Akt/mTOR signaling pathway.
    Hu C; Zhao X; Cui C; Zhang Y; Zhu Q; Yin H; Han S
    Theriogenology; 2024 Jan; 214():173-181. PubMed ID: 37879287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-4465 directly targets PTEN to inhibit AKT/mTOR pathway-mediated autophagy.
    Tao Z; Feng C; Mao C; Ren J; Tai Y; Guo H; Pu M; Zhou Y; Wang G; Wang M
    Cell Stress Chaperones; 2019 Jan; 24(1):105-113. PubMed ID: 30421325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
    Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
    Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
    Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
    Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
    Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
    Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated
    Zhao Y; Wang Y; Wang Y
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29175997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
    Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
    J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of miR-22-3p in chicken hierarchical follicles promotes granulosa cell proliferation, steroidogenesis, and lipid metabolism via PTEN/PI3K/Akt/mTOR signaling pathway.
    Deng X; Ning Z; Li L; Cui Z; Du X; Amevor FK; Tian Y; Shu G; Du X; Han X; Zhao X
    Int J Biol Macromol; 2023 Dec; 253(Pt 7):127415. PubMed ID: 37848113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2.
    Wang G; Feng L; Liu C; Han Z; Chen X
    Int Heart J; 2024; 65(3):528-536. PubMed ID: 38825497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway.
    Sun T; Duan L; Li J; Guo H; Xiong M
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy.
    Tang LQ; Wang W; Tang QF; Wang LL
    BMC Cardiovasc Disord; 2024 Jan; 24(1):18. PubMed ID: 38172711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
    Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
    BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA3650 Promotes Gastric Cancer Proliferation and Migration through the PTEN/PI3K-AKT-mTOR and Hippo Pathways.
    Yang X; Wen J; He Q; Wang S; Ruan Q; Liao Q; He J; Fang S; Liu C; Tang H
    Protein Pept Lett; 2023; 30(11):966-973. PubMed ID: 38031771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
    Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV inhibits idiopathic pulmonary fibrosis through activation of autophagy by miR-21-mediated PTEN/PI3K/AKT/mTOR pathway.
    Li T; Gao X; Jia R; Sun Y; Ding Y; Wang F; Wang Y
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):128-136. PubMed ID: 38430031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-22 inhibits myocardial fibrosis in rats with myocardial infarction by targeting PTEN/Akt/mTOR signaling pathway.
    Li B; Liang C; Lv Y; Tan Y; Chen W
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):28-33. PubMed ID: 38372117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.